Sun Pharma Posts Surprise Net Loss Of Rs. 219 Crore In Q2FY19

Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Sun Pharmaceutical Industries Ltd. reported a surprise loss for the quarter ended September owing to a one-off anti-trust litigation provision. In an exchange filing, the country's leading drug manufacturing company said it posted net loss to the tune of Rs. 219 crore in Q2FY19 in comparison to profit of Rs. 912 crore in the same quarter in the year ago period.

    Sun Pharma Posts Surprise Net Loss Of Rs. 219 Crore In Q2FY19
     

    Revenue at the company during the reporting period grew by 4% to Rs 6,938 crore year-on-year. This is lower than the analyst estimate of Rs. 7,600 crore.

    Operating income or the earnings before interest, tax, depreciation and amortisation increased 11% to Rs 1,531 crore. The operating margin increased to 22.5%, posting a surge of 180 basis points. 1 basis point is one-hundredth of a percentage point.

    A one-time loss of Rs.1,217 crore has been incurred by the pharma major for the estimated settlement amount payable in lieu of all the pending plantiffs in relation to Modafini, sleep apnea drug, in the US.

    "Our soft Q2 performance is not a reflection of the underlying health of the overall business," said Dilip Shanghvi, its managing director. "We continue to focus on strengthening our core operations and enhancing our overall efficiencies."

    Ahead of the results, shares of Sun Pharma dropped 4.7% to Rs 561.70 per share.

    Goodreturns.in

    Read more about: sun pharma earnings
    Story first published: Tuesday, November 13, 2018, 18:13 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more